The effectiveness of 111In-PSMA RGS is moderate due to interfering tracer accumulation in surrounding organs, leading to a more limited tumor-to-background ratio (TBR) in vivo compared with ex vivo. This evidence concerns the gene FOLH1 and neoplasm.